News Digest / Ticker: ALDX

Ticker: ALDX

06:07pm, Wednesday, May 14, 2025

Aldeyra Therapeutics Reports Q1 2025 Losses Amidst Strong Cash Position and Clinical Pipeline Potential

Company Overview: Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) is a clinical-stage biotechnology company dedicated to developing innovative therapies for immune-mediated and metabolic diseases. As of March 31, 2025, the company reported a net loss of approximately $9.93 million. Financial Summary: ...

05:43am, Thursday, Sep 19, 2024

Earnings Spotlight: Key Reports to Watch This September 19, 2024